53
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence

, , , &
Pages 1025-1035 | Published online: 08 Jun 2016

References

  • CheyWDWongBCPractice Parameters Committee of the American College of GastroenterologyAmerican College of Gastroenterology guideline on the management of Helicobacter pylori infectionAm J Gastroenterol20071021808182517608775
  • KustersJGvan VlietAHMKuipersEJPathogenesis of Helicobacter pylori infectionClin Microbiol Rev20061944949016847081
  • PetersonWLFendrickAMCaveDRPeuraDAGarabedian-RuffaloSMLaineLHelicobacter pylori-related disease. Guidelines for testing and treatmentArch Intern Med20001601285129110809031
  • CalvetXGarcíaNLópezTGisbertJPGenéERoqueMA meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAliment Pharmacol Ther20001460360910792124
  • KatelarisPHForbesGMTalleyNJCrottyBA randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE studyGastroenterology20021231763176912454831
  • VakilNLanzaFSchwartzHBarthJSeven-day therapy for Helicobacter pylori in the United StatesAliment Pharmacol Ther2004209910715225176
  • LeeMKempJACanningAEganCTataronisGFarrayeFAA randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapyArch Intern Med19991592312231610547171
  • GrahamDYLewGMMalatyHMFactors influencing the eradication of Helicobacter pylori with triple therapyGastroenterology19921024934961732120
  • DuckWMSobelJPrucklerJMAntimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United StatesEmerg Infect Dis2004101088109415207062
  • VairaDZulloAVakilNSequential therapy versus standard triple-drug therapy for Helicobacter pylori eradicationAnn Intern Med200714655656317438314
  • GisbertJPCalvetXHelicobacter pylori “test-and-treat” strategy for management of dyspepsia: a comprehensive reviewClin Transl Gastroenterol20134e3223535826
  • JaakkimainenRLBoyleETudiverFIs Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysisBMJ19993191040104410521198
  • GisbertJPPajaresJMStool antigen test for the diagnosis of Helicobacter pylori infection: a systematic reviewHelicobacter2004934736815270750
  • VakilNZulloARicciCHassanCVairaDDuplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patientsAliment Pharmacol Ther2008281304130818774949
  • CheyWDFendrickAMNoninvasive Helicobacter pylori testing for the test-and-treat strategy: a decision analysis to assess the effect of past infection on test choiceArch Intern Med20011612129213211570943
  • DaviesRCrabbeDRoderickPGoddardJRRafteryJPatelPA simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancersHealth Care Manag Sci2002524925812437272
  • ElwynGTaubertMDaviesSBrownGAllisonMPhillipsCWhich test is best for Helicobacter pylori? A cost-effectiveness model using decision analysisBr J Gen Pract20075740140317504592
  • HolmesKPFangJCJacksonBRCost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice patternBMC Health Serv Res20101034421176158
  • MasucciLBlackhouseGGoereeRCost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysisOnt Health Technol Assess Ser201313128
  • VakilNRhewDSollAOfmanJJThe cost-effectiveness of diagnostic testing strategies for Helicobacter pyloriAm J Gastroenterol2000951691169810925969
  • CullenKPBroderickBMJayaramJFlynnBO’ConnorHJEvaluation of the Helicobacter pylori stool antigen (HpSA) test in routine clinical practice – is it patient-friendly?Ir Med J20029530530612537325
  • GisbertJPPajaresJM13C-urea breath test in the diagnosis of Helicobacter pylori infection – a critical reviewAliment Pharmacol Ther2004201001101715569102
  • Resource-Based Relative Value Scale (RBRVS)The Essential RBRVS 2014: A Comprehensive Listing of RBRVS Values for CPT and HCPCS CodesEden Prairie, MNOptumInsight, Inc2014
  • AriasECurtinLRWeiRAndersonRNU.S. decennial life tables for 1999–2001, United States life tablesNatl Vital Stat Rep200857136
  • AsakaMSepulvedaARSugiyamaTGrahamDYGastric cancerMobleyHLTMendzGLHazellSLHelicobacter pylori: Physiology and GeneticsWashington, DCAmerican Society for Microbiology (ASM) Press2001 Available from: http://www.ncbi.nlm.nih.gov/books/NBK2445/Accessed March 6, 2014
  • ChibaNVan ZantenSJSinclairPFergusonRAEscobedoSGraceETreating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment – Helicobacter pylori positive (CADET-Hp) randomised controlled trialBMJ20023241012101811976244
  • ErstadBLCost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleedingCrit Care Med2004321277128315187506
  • HojoMMiwaHNagaharaASatoNPooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infectionScand J Gastroenterol20013669070011444467
  • HowardKLordSJSpeerAGibsonRNPadburyRKearneyBValue of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategiesInt J Technol Assess Health Care20062210911816673687
  • KuipersEJReview article: exploring the link between Helicobacter pylori and gastric cancerAliment Pharmacol Ther199913Suppl 131110209681
  • LaineLEstradaRTrujilloMKniggeKFennertyMBEffect of proton pump inhibitor therapy on diagnostic testing for Helicobacter pyloriAnn Intern Med19981295475509758575
  • Micromedex 2.0 [homepage on the Internet]Red Book Online. Thomson Reuters; 2014 Available from: http://www.micromedexsolutions.com/home/dispatchAccessed March 5, 2015
  • SlawskyKCyrPLOlchanskiNHowdenCWCost-effectiveness of diagnostic strategies for H. pylori infection in a high prevalence populationGastroenterology2011140Suppl 1S203
  • YabroffKRLamontEBMariottoACost of care for elderly cancer patients in the United StatesJ Natl Cancer Inst200810063064118445825
  • YehJMHurCKuntzKMEzzatiMGoldieSJCost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancerCancer20101162941295320564399
  • YouJHTsuiKKWongRSChengGCost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillationPLoS One20127e3964022745801
  • WhiteheadSJAliSHealth outcomes in economic evaluation: the QALY and utilitiesBr Med Bull20109652121037243
  • CardenasVMMullaZDOrtizMGrahamDYIron deficiency and Helicobacter pylori infection in the United StatesAm J Epidemiol200616312713416306309
  • NivYHazaziRHelicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradicationHelicobacter200813566118205667
  • GrahamDYFishbachLRecent advances in clinical practice: Helicobacter pylori treatment in the era of increasing antibiotic resistanceGut2010591143115320525969